Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement.

Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement.

In this overview we review and model how radiotherapy tumour control and complication rates vary with dose, fractionation, schedule duration, irradiated volume and use of chemotherapy for stage III non-small cell lung cancer (NSCLC), and use the modelling to study the effectiveness of different NSCL...

Full description

Bibliographic Details
Main Authors:	Fenwick, J, Nahum, A, Malik, Z, Eswar, C, Hatton, M, Laurence, V, Lester, J, Landau, D
Format:	Journal article
Language:	English
Published:	2009

Similar Items

Influence of dose calculation algorithms on isotoxic dose-escalation of non-small cell lung cancer radiotherapy.
by: Panettieri, V, et al.
Published: (2010)

UK proposal for three parallel dose escalation studies in radiotherapy (RT) for Stage I-III non-small cell lung cancer (NSCLQC)-DEAL-RT
by: Hughes, S, et al.
Published: (2007)

A phase I/II trial of concurrent chemo-radiation with dose-escalated radiotherapy in patients with stage II or stage III non-small cell lung cancer
by: Landau, D, et al.
Published: (2013)

Dose-individualisation for lung cancer radiotherapy - are we ready?
by: Malik, Z, et al.
Published: (2007)

ISO-NTCP customisation of the prescription dose in lung-tumour radiotherapy
by: Malik, Z, et al.
Published: (2007)

Optimizing collimator margins for isotoxically dose-escalated conformal radiation therapy of non-small cell lung cancer.
by: Warren, S, et al.
Published: (2014)

Radiation dose escalation in stage III non-small-cell lung cancer.
by: William Thomas Sause, et al.
Published: (2011-11-01)

The I-START trial: ISoToxic Accelerated RadioTherapy in locally advanced non-small cell lung cancer
by: Lester, J, et al.
Published: (2012)

Moderately Escalated Hypofractionated (Chemo)Radiotherapy Delivered with Helical Intensity-Modulated Technique in Stage III Unresectable Non-Small Cell Lung Cancer
by: Vittorio eDonato, et al.
Published: (2013-11-01)

Dosimetric Feasibility of Dose Escalation Using SBRT Boost for Stage III Non-Small Cell Lung Cancer
by: Jaroslaw T. Hepel, et al.
Published: (2012-09-01)

Biomathematical model-based analysis of a standard UK dose and fractionation lung tumour radiotherapy protocol
by: Malik, Z, et al.
Published: (2007)

Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer
by: Qin Zhang, et al.
Published: (2022-01-01)

Using a Monte Carlo model to predict dosimetric properties of small radiotherapy photon fields.
by: Scott, A, et al.
Published: (2008)

Robotic Stereotactic Radiotherapy for Intracranial Meningiomas—An Opportunity for Radiation Dose De-Escalation
by: Hanna Grzbiela, et al.
Published: (2023-11-01)

A current review of dose-escalated radiotherapy in locally advanced non-small cell lung cancer
by: Ma Li, et al.
Published: (2019-03-01)

Improved Outcomes With Dose Escalated Hypofractionated Radiotherapy for Prostate Cancer
by: Mackenzie, J, et al.
Published: (2011)

Phase I Study of Etoposide and Cisplatin Chemotherapy Dose Escalation  with Concurrent Twice-daily Radiotherapy for Patients  with Limited-stage Small Cell Lung Cancer
by: Jing YOU, et al.
Published: (2017-01-01)

Numerical Study of Effects of Bladder Filling on Prostate Positioning In Radiotherapy
by: Krywonos, J, et al.
Published: (2009)

THE ROLE OF RADIOTHERAPY DELAY IN THE CHEMORADIATION TREATMENT FOR STAGE III INOPERABLE NON-SMALL CELL LUNG CANCER
by: E. P. Solov’eva, et al.
Published: (2016-02-01)

The impact of cardiac radiation dosimetry on survival following radiotherapy for non-small cell lung cancer
by: Vivekanandan, S, et al.
Published: (2017)

Isotoxic dose escalation with real-time imaging on an MR-linac in lung radiation therapy
by: Bendall, L, et al.
Published: (2018)

Impact of schedule duration on head and neck radiotherapy: accelerated tumor repopulation versus compensatory mucosal proliferation.
by: Fenwick, J, et al.
Published: (2012)

Impact of schedule duration on head and neck radiotherapy: Accelerated tumor repopulation versus compensatory mucosal proliferation
by: Fenwick, J, et al.
Published: (2012)

Three Dimensional Conformal Radiotherapy Combined with Concurrent Chemotherapy for Stage Ⅲ Non-small Cell Lung Cancer
by: Lili GAO, et al.
Published: (2009-09-01)

FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer
by: Sébastien Thureau, et al.
Published: (2018-10-01)

Normal tissue doses during isotoxically dose escalated lung radiation therapy using MR-linacs
by: Bendall, L, et al.
Published: (2018)

Prognostic significance of genetic variants in GLUT1 in stage III non‐small cell lung cancer treated with radiotherapy
by: Min Kyu Kang, et al.
Published: (2021-03-01)

Treatment outcome and toxicity of intensity-modulated (chemo) radiotherapy in stage III non-small cell lung cancer patients
by: Govaert Stephanie LA, et al.
Published: (2012-09-01)

Review of hypofractionated small volume radiotherapy for early-stage non-small cell lung cancer.
by: Brock, J, et al.
Published: (2008)

Early mucosal reactions during and after head-and-neck radiotherapy: dependence of treatment tolerance on radiation dose and schedule duration.
by: Fenwick, J, et al.
Published: (2008)

Clinical and dosimetric factors impacting radiation pneumonitis in isotoxically dose-escalated NSCLC
by: Vivekanandan, S, et al.
Published: (2017)

Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer.
by: Guckenberger, M, et al.
Published: (2012)

Combined Radiomics–Clinical Model to Predict Radiotherapy Response in Inoperable Stage III and IV Non-Small-Cell Lung Cancer
by: Wenrui Chen MS, et al.
Published: (2022-12-01)

Evaluation of Postoperative Radiotherapy Effect on Survival of Resected Stage III-N2 Non-small Cell Lung Cancer Patients
by: Fei Gao, et al.
Published: (2020-07-01)

DOSE-ESCALATED EXTERNAL BEAM RADIOTHERAPY DURING HORMONO-RADIOTHERAPY FOR PROSTATE CANCER
by: Yu. V. Gumenetskaya, et al.
Published: (2016-07-01)

Neoadjuvant Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer
by: David J. Sher
Published: (2017-12-01)

Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era
by: Huanhuan Li, et al.
Published: (2023-08-01)

Hypofractionated radiotherapy with immunochemotherapy for extensive-stage small-cell lung cancer
by: Chaoyuan Liu, et al.
Published: (2023-06-01)

A pilot study (SWOG S0429) of weekly cetuximab and chest radiotherapy for poor-risk stage III non-small cell lung cancer
by: Yuhchyau eChen, et al.
Published: (2013-08-01)

Thermal ablation versus radiotherapy for inoperable stage III non-small cell lung cancer: a propensity score matching analysis
by: Wei-Yu Yang, et al.
Published: (2023-12-01)